ACADIAN ASSET MANAGEMENT LLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$132
+10.9%
58,069
-55.9%
0.00%0.0%
Q1 2023$119
+7.2%
131,7710.0%0.00%0.0%
Q4 2022$111
-99.9%
131,771
-7.3%
0.00%0.0%
Q3 2022$115,000
-18.4%
142,1600.0%0.00%0.0%
Q2 2022$141,000
-38.2%
142,160
+1.5%
0.00%0.0%
Q1 2022$228,000
+17.5%
140,118
+72.6%
0.00%0.0%
Q4 2021$194,000
-2.5%
81,166
+96.9%
0.00%0.0%
Q3 2021$199,000
+46.3%
41,231
-19.1%
0.00%0.0%
Q2 2021$136,000
+112.5%
50,979
+143.5%
0.00%
Q1 2021$64,000
-80.6%
20,936
-77.4%
0.00%
-100.0%
Q4 2020$330,000
-47.6%
92,502
-41.1%
0.00%
-66.7%
Q3 2020$630,000
+27.5%
157,134
-13.5%
0.00%
+50.0%
Q2 2020$494,000
+14.6%
181,755
+129.4%
0.00%0.0%
Q4 2019$431,000
+171.1%
79,233
+86.9%
0.00%
+100.0%
Q2 2019$159,000
-6.5%
42,3940.0%0.00%0.0%
Q1 2019$170,000
+36.0%
42,394
+23.9%
0.00%0.0%
Q4 2018$125,000
-57.3%
34,2290.0%0.00%0.0%
Q3 2018$293,000
+24.2%
34,229
+59.2%
0.00%0.0%
Q2 2018$236,000
+118.5%
21,494
+129.3%
0.00%
Q1 2018$108,000
+5300.0%
9,375
+5796.2%
0.00%
Q2 2016$2,0001590.00%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$8,746,0001.82%
Telemetry Investments, L.L.C. 263,975$705,0000.97%
CHI Advisors LLC 719,132$1,920,0000.45%
BVF INC/IL 3,678,626$9,822,0000.37%
EcoR1 Capital, LLC 3,579,377$9,557,0000.36%
Orbimed Advisors 8,053,298$21,502,0000.22%
Stonepine Capital Management, LLC 46,886$125,0000.06%
Ikarian Capital, LLC 100,000$267,0000.02%
ALGERT GLOBAL LLC 19,737$53,0000.02%
Windsor Creek Advisors, LLC 14,786$39,0000.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders